FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Authority Hl7

17,520 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 8000 - 8200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
hl7.terminologyR5v3-EmergencyPharmacySupplyTypeEmergencyPharmacySupplyTypeactive2014-03uvtho
hl7.terminologyR5v3-RoleClassActiveIngredientRoleClassActiveIngredientactive2014-03uvtho
hl7.terminologyR5v3-ActClassFinancialAdjudicationActClassFinancialAdjudicationactive2014-03uvtho
hl7.terminologyR5v3-ActRelationshipMatchesTriggerActRelationshipMatchesTriggeractive2014-03uvtho
hl7.fhir.uv.vhdirR4digitalcertificatetrustframeworkVhDir Digital Certificate Trust Framework Value Settrial-use2pa2018-02uvfhir
hl7.terminologyR5v3-LiquidLiquidEmulsionLiquidLiquidEmulsionactive2014-03uvtho
hl7.terminologyR5v3-xMedicinex_Medicineactive2014-03uvtho
hl7.terminologyR5v3-xAdministeredSubstancex_AdministeredSubstanceactive2014-03uvtho
hl7.fhir.uv.cpgR4cpg-activity-type-vsCPG Activity Type Value Setactivecds2024-11uvfhir
hl7.fhir.uv.cpgR4cpg-casefeature-pertinence-vsCPG Case Feature Pertinence Value Setactivecds2024-11uvfhir
hl7.fhir.uv.cpgR4cpg-casefeature-type-vsCPG Case Feature Type Value Setactivecds2024-11uvfhir
hl7.terminologyR5v3-EntityClassHolderEntityClassHolderactive2014-03uvtho
hl7.terminologyR5v3-QualityMeasureSectionTypeQualityMeasureSectionTypeactive2014-03uvloinc
ca.on.ppr.r4R4ProviderRoleAffiliationType-providerProviderAffiliationTypedraft
hl7.terminologyR5v3-ActClassAccessionActClassAccessionactive2014-03uvtho
hl7.terminologyR5v3-LocalRemoteControlStateLocalRemoteControlStateactive2014-03uvtho
us.nlm.vsacR42.16.840.1.113883.1.11.12199LanguageAbilityProficiencyactive2024-06ustho
hl7.terminologyR5v3-LanguageAbilityProficiencyLanguageAbilityProficiencyactive2014-03uvtho
us.nlm.vsacR42.16.840.1.113883.1.11.12249LanguageAbilityModeactive2024-06ustho
hl7.terminologyR5v3-LanguageAbilityModeLanguageAbilityModeactive2014-03uvtho
hl7.terminologyR5v3-DrugEntityDrug Entityactive2022-10uvtho
hl7.terminologyR5v3-EntityCodeEntityCodeactive2014-03uvtho
hl7.terminologyR5v3-materialFormmaterialFormretired2014-03uvtho
hl7.terminologyR5v3-GenderStatusGenderStatusactive2014-03uvtho
fhir.nigeriaImmunizationR4IMMZD16-ValueSetIMMZD16-ValueSet for AEFI Treatmentdraft2025-05usinternal
us.nlm.vsacR42.16.840.1.113883.11.20.9.61Care Modelactive2024-06ussct
us.nlm.vsacR42.16.840.1.113883.1.11.19185Religious Affiliationactive2024-06ustho
hl7.fhir.eu.imaging-manifest-r5R5periods-of-life-value-setPeriods of Lifedraft2025-07eusct
hl7.fhir.eu.imaging-r5R5periods-of-life-value-setPeriods of Lifedraft2025-07eusct
us.nlm.vsacR42.16.840.1.113883.11.20.7.1SupportedFileFormatsactive2024-06ustho
hl7.fhir.us.splR5valueset-AllNDCProductsAll NDC Productstrial-use1brr2025-07usndc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.1Pregnancy Statusactive2023-08ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.10Pap Smear Testsactive2023-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.11HIV Testsactive2023-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.12Human Papilloma Virus Testsactive2023-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.13Chlamydia Trachomatis Testsactive2023-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.14Neisseria Gonorrhoeae Testsactive2023-07usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.17Contraceptive Typeactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.18Contraception Not Used Reasonactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.209Yes and No Answersactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.21Contraceptive Provision Methodactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.210Pap Smear Resultsactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.211Contraceptive discussionactive2023-08usloinc
us.nlm.vsacR42.16.840.1.113762.1.4.1166.24Clinical Provider Roleactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.29Insurance Coverage Typeactive2023-07us
us.nlm.vsacR42.16.840.1.113762.1.4.1166.3Organism Detectionactive2023-07ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.31English Proficiencyactive2023-07ussct
hl7.fhir.us.vitalsR4LowOnlyNumericResultIntVSLow Only Numeric Result Interpretation value setdraft2024-10ustho
nhsd.assets.stu3R3ValueSet-PEC-ExemptionType-1PEC Exemption Typedraft2017-12
nhsd.assets.stu3R3ValueSet-PersonRelationshipType-1Person Relationship Typedraft2017-10
nhsd.assets.stu3R3ITK-PatientAllergyChangeType-1Patient Allergy Change Typedraft2017-12
nhsd.assets.stu3R3ITK-PatientMedicationChangeType-1Patient Medication Change Typedraft2017-09
nhsd.assets.stu3R3ITK-ConditionFlag-1ITK Condition Flagdraft2018-04
nhsd.assets.stu3R3ValueSet-eRS-AdditionalRequirementType-1eRS Additional Requirement Typedraft
nhsd.assets.stu3R3ITK-RecipientType-1ITK Recipient Typeactive2018-08
nhsd.assets.stu3R3ITK-BusAcknowledgement-1ITK Business Acknowledgementdraft2017-09
nhsd.assets.stu3R3ITK-InfAcknowledgement-1ITK Infrastructure Acknowledgementdraft2017-12
nhsd.assets.stu3R3ITK-ResponseCodes-1ITK Response Codesactive2018-08
nhsd.assets.stu3R3eRS-BookableType-1eRS Bookable Typedraft
nhsd.assets.stu3R3eRS-ClinicType-1eRS Clinic Typedraft
uk.nhsdigital.r4.testR4d2a51dd0-9e86-4cea-9064-077637cb79b7ERSAppointmentCancellationReasondraft
uk.nhsdigital.r4.testR4d2a51dd0-9e86-4cea-9064-077637cb79b7ERSReferralStatedraft
uk.nhsdigital.r4.testR4bb928767-263e-457c-9ee0-1a3d239ddc10ERSClinicTypedraft
nhsd.assets.stu3R3eRS-CommissioningProvisioning-1eRS Commissioning Provisioningdraft
nhsd.assets.stu3R3eRS-CommissioningType-1eRS Commissioning Typedraft
nhsd.assets.stu3R3ITK-MessageEvent-2ITK Message Eventactive2018-08
nhsd.assets.stu3R3eRS-GenderTreated-1eRS Gender Treateddraft
nhsd.assets.stu3R3ValueSet-eRS-OrganisationType-1eRS Organisation Typedraft
NHSDigital.FHIR.STU3R3eRS-ReferralCancellationReason-1eRS Referral Cancellation Reasonactive2022-03
nhsd.assets.stu3R3eRS-ReferralTreatmentMissingReason-1eRS Referral Treatment Missing Reasondraft
nhsd.assets.stu3R3eRS-RequestFlowType-1eRS Request Flow Typedraft
nhsd.assets.stu3R3eRS-FetchOutcomeType-1DO NOT USE - eRS Fetch Outcome Typeretired
nhsd.assets.stu3R3eRS-Specialty-1eRS Referral Typeactive
nhsd.assets.stu3R3eRS-Specialty-1eRS Specialtydraft
nhsd.assets.stu3R3eRS-ReferralRequestStatus-1eRS Referral Request Statusdraft
nhsd.assets.stu3R3ValueSet-eRS-AppointmentType-1eRS Appointment Typedraft
nhsd.assets.stu3R3eRS-CapacityAlert-1eRS Capacity Alertdraft
nhsd.assets.stu3R3eRS-CapacityStatus-1eRS Capacity Statusdraft
nhsd.assets.stu3R3eRS-RequestType-1eRS Request Typedraft
nhsd.assets.stu3R3eRS-ServiceSearch-SortBy-1eRS ServiceSearch Sort By - DO NOT USEretired
nhsd.assets.stu3R3eRS-SortBy-1eRS Sort Bydraft
nhsd.assets.stu3R3eRS-IWT-1eRS Indicative Wait Timedraft
nhsd.assets.stu3R3eRS-ReferralLetterIntention-1eRS Referral Letter Intentiondraft
hl7.terminologyR5v3-ParticipationAuthenticatorParticipationAuthenticatoractive2014-03uvtho
hl7.terminologyR5v3-ParticipationLegalAuthenticatorParticipationLegalAuthenticatoractive2014-03uvtho
hl7.terminologyR5v3-SwabDrugFormSwabDrugFormactive2014-03uvtho
hl7.terminologyR5v3-PersonalAndLegalRelationshipRoleTypePersonalAndLegalRelationshipRoleTypeactive2023-06uvtho
de.basisprofil.r4R4valueset-wg14WG14 ValueSetactive2025-06
HIE2.packagesR4results-laboratory-blood-abo-rh-grp-gps-uv-ipsResults Laboratory ABO+RH Group (GPS) - IPSactive2022-01uvsct
hl7.fhir.us.registry-protocolsR4LesionComplexityComplexity of the Lesionactivecic2023-11usfhir
hl7.fhir.us.registry-protocolsR4CABGIndicationCABG Indicationactivecic2023-11usfhir
hl7.fhir.us.medmorphR4us-ph-computable-valueset-exampleUS Public Health Computable ValueSet Exampledraft2022-07us
hl7.fhir.us.ecrR4us-ph-computable-valueset-exampleUS Public Health Computable ValueSet Exampledraft2022-05us
hl7.fhir.us.ph-libraryR4us-ph-valueset-computable-exampleUS Public Health ValueSet - Computable Exampledraft2022-07us
hl7.fhir.us.breast-radiologyR4rde1562-laterality-from-landmarkRDE1562 Laterality from landmarkdraft2022-10usfhir
hl7.fhir.us.breast-radiologyR4rde1565-typeRDE1565 Typedraft2022-10usfhir
hl7.fhir.us.breast-radiologyR4rde1568-distributionRDE1568 Distributiondraft2022-12usfhir
hl7.fhir.us.breast-radiologyR4rde1571-associated-featuresRDE1571 Associated featuresdraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1576-shapeRDE1576 Shapedraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1577-typeRDE1577 Typedraft2022-10usfhir
hl7.fhir.us.breast-radiologyR4rde1578-densityRDE1578 Densitydraft2022-10usfhir
hl7.fhir.us.breast-radiologyR4rde1579-marginRDE1579 Margindraft2022-10usfhir
hl7.fhir.us.breast-radiologyR4rde1580-orientationRDE1580 Orientationdraft2022-10usfhir
hl7.fhir.us.breast-radiologyR4rde1586-assessment-categoryRDE1586 Assessment categorydraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1587-breast-composition-categoryRDE1587 Breast composition categorydraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1588-breast-lateralityRDE1588 Breast lateralitydraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1589-implant-presenceRDE1589 Implant presencedraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1590-prior-mastectomyRDE1590 Prior mastectomydraft2022-11usfhir
hl7.fhir.us.breast-radiologyR4rde1602-typeRDE1602 Typedraft2022-12usfhir
hl7.fhir.it.lab-reportR4aifa-aicAIFA AICactive2024-03itinternal
hl7.fhir.it.terminologyR4aifa-geAIFA Gruppo di Equivalenzaactive2025-06itinternal
hl7.org.nz.fhir.ig.formularyR4Batc-codeATC codesactive2025-07nzatc
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.20.5.4--20200901000000AanduidingBijNummerCodelijstactivenloid
hl7.terminologyR5verificationresult-can-push-updatesCan-push-updatesactivepa2024-04uvtho
ca.on.oh-olisR4olis-InterpretationProviderInterpretationactivetho
hl7.fhir.us.breast-radiologyR4rde1556-presenceRDE1556 Presencedraft2022-12usfhir
us.nlm.vsacR42.16.840.1.113762.1.4.1206.34AbnormalityOfGaitAndMobilityactive2021-07usicd
HIE2.packagesR4absent-or-unknown-allergies-uv-ipsAbsent or Unknown Allergies - IPSactive2022-01uvfhir
hl7.cda.uv.ipsR42.16.840.1.113883.11.22.61--20180127221947Absent or Unknown Devicesdraft2024-08uvfhir
HIE2.packagesR4absent-or-unknown-immunizations-uv-ipsAbsent or Unknown Immunization - IPSactive2022-01uvfhir
HIE2.packagesR4absent-or-unknown-medications-uv-ipsAbsent or Unknown Medication - IPSactive2022-01uvfhir
HIE2.packagesR4absent-or-unknown-problems-uv-ipsAbsent or Unknown Problems - IPSactive2022-01uvfhir
hl7.eu.fhir.pcspR4absent-or-unknown-procedures-uv-ipsAbsent or Unknown Procedures - IPStrial-use22022-11eufhir
hl7.fhir.us.mcodeR4mcode-tumor-size-units-vsTumor Size Units Value Setactive3cic2025-02usucum
hl7.terminologyR5cql-access-modifierCQL Access Modifierdraftcds2024-02uvtho
hl7.terminologyR5v3-ActEncounterAccommodationCodeActEncounterAccommodationCodeactive2014-03uvtho
hl7.terminologyR5v3-AcknowledgementConditionAcknowledgementConditionactive2014-03uvtho
hl7.terminologyR5v3-AcknowledgementTypeAcknowledgementTypeactive2014-03uvtho
ee.hl7.fhir.base.r5R5ee-act-priorityAct Prioritydraft2023-08eetho
ee.fhir.terminologyR5act-priorityAct Priorityactive2025-06eetho
hl7.terminologyR5v3-ActConsentDirectiveTypeActConsentDirectiveTypeactivesec2019-03uvtho
hl7.terminologyR5v3-ActConsentDirectiveActConsentDirectiveactive2014-03uvtho
hl7.terminologyR5v3-ActPrivacyLawActPrivacyLawactive2014-03uvtho
hl7.terminologyR5v3-ActPrivacyPolicyActPrivacyPolicyactive2014-03uvtho
hl7.terminologyR5v3-ActInformationSensitivityPolicyActInformationSensitivityPolicyactive2014-03uvtho
hl7.cda.uv.ipsR42.16.840.1.113883.11.22.22--20170502000000ActStatusActiveCompletedAbortedCancelleddraft2024-08uvtho
hl7.cda.uv.ipsR42.16.840.1.113883.11.22.12--20170330000000ActStatusActiveCompletedAbortedSuspendeddraft2024-08uvtho
ch.fhir.ig.ch-termR4ActSubstanceAdminSubstitutionCodeActSubstanceAdminSubstitutionCodeactive2025-05chtho
signal.core.r4R4questionnaire-ccars-action-typesQuestionnaire CCARS Action Typesdraft1paus
hl7.terminologyR5adverse-event-clinical-research-seriousness-criteriaAdverse Event Clinical Research Seriousness Criteriaactive1brr2023-07uvncit
de.netzwerk-universitaetsmedizin.ebm-cpgR5vs-action-selection-behavior-requiredAction Selection Behavior Requireddraft2022-11uvfhir
hl7.terminologyR5v3-ActAdjudicationResultActionCodeActAdjudicationResultActionCodeactive2014-03uvtho
hl7.fhir.nl.zorgviewerR3ACPTreatmentCodelistACP behandelingen waardelijstactive2025-07nlsct
hl7.fhir.uv.cpgR4cpg-active-condition-vsCPG Active Condition Value Setactivecds2024-11uvtho
fhir.cqf.commonR4active-conditionCQF Active Conditionactive2019-07ustho
hl7.eu.fhir.pcspR4activeResolved-condition-vsActive or resolved Conditiondraft2025-07eutho
ch.fhir.ig.ch-termR4ActivePharmaceuticalIngredientActivePharmaceuticalIngredientactive2025-05chsct
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.12.13.3--20200901000000ActiviteitCodelijstactivenloid
hl7.fhir.us.vrdrR4vrdr-activity-at-time-of-death-vsActivity at Time of Death ValueSetactivepher2024-10usfhir tho
ch.fhir.ig.ch-epr-fhirR4PpqmActorIdentifierTypeCH PPQm Actor Identifier Typeactive2025-05chietf
ch.fhir.ig.ch-epr-ppqmR4PpqmActorIdentifierTypePPQm Actor Identifier Typeactive2023-12chietf
hl7.fhir.us.nhsn-dqmR4ach-encounter-classAcute Care Hospital Encounter Class ValueSettrial-use1pher2025-07ustho
hl7.fhir.us.nhsn-dqmR4ach-encounter-statusAcute Care Hospital Encounter Status ValueSettrial-use1pher2025-07usfhir
hl7.eu.fhir.pcspR4vs-Gvhd-acute-grade-eu-pcspAcute Gvhd Gradedraft2025-07euinternal tho
hl7.eu.fhir.pcspR4vs-Gvhd-chronic-grade-eu-pcspChronic Gvhd conditiondraft2025-07euinternal tho
us.nlm.vsacR42.16.840.1.113883.1.11.10416Financially Responsible Party Type Value Setactive2024-06ustho
us.nlm.vsacR42.16.840.1.113883.11.20.9.20Telecom Use (US Realm Header)active2024-06ustho
us.nlm.vsacR42.16.840.1.113883.1.11.19579Family Member Valueactive2024-06ustho
us.nlm.vsacR42.16.840.1.113883.11.20.9.38Smoking Statusactive2024-06ussct
hl7.fhir.uv.toolsR5additional-binding-purposeAdditional Binding Purpose ValueSetinformative4fhir2025-07uvfhir
ch.fhir.ig.ch-termR4condition-categoryCondition Category Codesactive2025-05ch
hl7.fhir.uv.cardx-ciedR5cied-connectivity-state-modifier-vsCIED Connectivity Status Modifier Value Settrial-use2cic2025-07uvfhir
ForgePatientChart.0830R4telus-address-stateTELUS ValueSet - Address Statedraft2020-11
hl7.fhir.us.davinci-crdR4locationAddressTypeCRD Location Address Types Value Settrial-use4fm2025-07usfhir
ee.fhir.terminologyR5ads-adr-idADS AdrIdactive2025-06eeinternal
ee.fhir.terminologyR5ads-oidADS Oidactive2025-06eeinternal
hl7.fhir.us.davinci-hrexR4hrex-coverage-relationshipHRex Coverage Relationship ValueSetdraft0cic2025-04usfhir tho
us.nlm.vsacR42.16.840.1.113762.1.4.1032.313Statin Allergen Groupingactive2024-03usvsac
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.12.16.1--20200901000000AdemhalingScoreCodelijstactivenlloinc
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.12.12.3--20200901000000AdemhalingsreactieCodelijstactivenloid
hl7.fhir.uv.emedicinal-product-infoR5administrableDoseFormAdministrable Pharmaceutical Dose Formactive2025-07uvfhir
hl7.terminologyR5v3-AdministrationDetectedIssueCodeAdministrationDetectedIssueCodeactive2014-03uvtho
ee.hl7.fhir.base.r5R5ee-administrative-genderAdministrative Genderdraft2023-08eefhir
ee.fhir.terminologyR5administrative-genderAdministrative Genderactive2025-06eefhir
ForgePatientChart.0830R4telus-administrative-genderTELUS ValueSet - Administrative Genderdraft2020-11fhir
fhir.kisumuhieR4gender-vsGenderdraft2025-06us
fhir.kenyaPSIGR4administrative-gender-vsAdministrative Genderactive2025-07usfhir
hl7.terminologyR5v3-xActEncounterReasonx_ActEncounterReasonactive2014-03uvtho
ca.ab.fhir.psabR4administrative-gender-abAdministrativeGender_ABdraft2024-06catho
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20200901000000AdresSoortCodelijstactivenltho
us.nlm.vsacR42.16.840.1.113762.1.4.1235.645Pneumococcal Vaccine HD_CN_ Allergyactive2025-04ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.638b.well Adult Tetanus Vaccine CNactive2025-04usvsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.648bwell COVID Vaccine CN_Metactive2025-04usvsac
hl7.eu.fhir.idea4rcR4adverse-event-type-eu-i4rcAdverse Event Typeactive2025-07eu
hl7.eu.fhir.idea4rcR4vs-affectedOrgan-eu-i4rcAffected Organs (surgery)active2025-07eufhir tho
hl7.eu.fhir.pcspR4vs-affectedOrgan-eu-pcspAffected Organs (surgery)draft2025-07euinternal sct
fhir.acme.affiliate-reportR4affiliate-type-vsAffiliate Type ValueSetdraft2025-05usinternal
hl7.fhir.us.registry-protocolsR4YesNoYes or Noactivecic2023-11ussct tho
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000AfnameprocedureCodelijstactivenlsct
hl7.fhir.us.davinci-pdexR4ProvenanceAgentTypeProvenance Agent Typeinformativefm2025-06usfhir tho
hl7.terminologyR5measure-aggregate-methodMeasure Aggregate Methodactivecqi2023-02uvtho
hl7.eu.fhir.idea4rcR4alcoholUsageStatus-athena-eu-i4rcAlcohol Usage Status: Athenaactive2025-07eu
hl7.eu.fhir.idea4rcR4alcoholUsageStatus-snomed-eu-i4rcAlcohol Usage Status: SNOMED CTactive2025-07eusct
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000AlcoholGebruikStatusCodelijstactivenlsct tho
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000AlertNaamCodelijstactivenlsct tho
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000AlertTypeCodelijstactivenlloinc
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20200901000000AlertheidCodelijstactivenloid
hl7.fhir.us.registry-protocolsR4StressTestCath PCI Selected Stress Testactivecic2023-11usloinc
fhir.cdc.opioid-cds-r4R4barbiturate-medicationsBarbiturate Medicationsactive2025-02us
fhir.cdc.opioid-cds-r4R4buprenorphine-and-methadone-medicationsBuprenorphine and Methadone medicationsactive2023-05us